SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.51 |
Enterprise Value ($M) | 7.67 |
Book Value ($M) | -9.27 |
Book Value / Share | -4.88 |
Price / Book | -0.70 |
NCAV ($M) | -9.27 |
NCAV / Share | -4.89 |
Price / NCAV | -0.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.15 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.19 |
Assets | 1.19 |
Liabilities | 10.46 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Hafner Ronald | 8.10 | ||
13G/A | Lind Global Fund II LP | 8.10 | -97.59 | |
13G | Armistice Capital, Llc | 9.99 | ||
13G/A | YA II PN, Ltd. | -100.00 | ||
13G/A | Grisard Felix | 2.80 | -96.69 | |
13G | Alpha Capital Anstalt | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
57,516 | 123,698 | 46.50 | |
1,201 | 22,680 | 5.30 | |
5,911 | 47,110 | 12.55 | |
5,310 | 64,371 | 8.25 | |
(click for more detail) |
Similar Companies | |
---|---|
NATR – Nature's Sunshine Products, Inc. | NERV – Minerva Neurosciences, Inc. |
NKTR – Nektar Therapeutics | NRBO – NeuroBo Pharmaceuticals, Inc. |
NRSN – NeuroSense Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io